KYIV, UKRAINE / ACCESSWIRE / November 19, 2024 / On the 1,000th day of Russia's war of aggression against Ukraine, the Romulus T. Weatherman Foundation reaffirms its unwavering commitment to the Ukrainian people by launching its Targeted Trauma Treatment (T3) Program.
This groundbreaking initiative will deliver essential PTSD treatment to Ukraine's elite defenders. Specifically tailored to meet the mental health needs of personnel with extensive combat experience, this program aims to profoundly improve the lives of soldiers and their families while bolstering Ukraine's fight for freedom and sovereignty.
The T3 Program leverages the advanced Stellate Ganglion Block (SGB) injection protocol, a proven trauma treatment that will help Ukrainian soldiers recover quickly from combat stress and return to duty. This cutting-edge treatment is a game-changer for Ukrainian warriors, enabling soldiers to regain their mental and emotional resilience and continue to play vital roles in defending their nation.
Andrew Duncan, co-founder of the R.T. Weatherman Foundation, stressed the importance of the program: "I've seen these soldiers carry the burden of an entire nation and the free world. The T3 Program is about giving them back their strength. These are the people standing between Ukraine and tyranny. By providing this trauma treatment, we are not only saving lives-we are ensuring Ukraine's defenders remain sharp, focused, and ready to win."
Meaghan Mobbs, President of the R.T. Weatherman Foundation and driving force of the T3 Program, is a dedicated advocate for Ukraine's military personnel. Since the onset of the full-scale invasion, she has traveled to Ukraine over 17 times, spearheading the delivery of $150 million in humanitarian aid and creating critical programs to support foreign fighters who have been wounded, killed, or reported missing in action.
"Trained and qualified fighters are one of Ukraine's most important assets," Mobbs said. "The T3 Program is about giving them the support they need to recover quickly and get back into the fight. We're not just treating trauma; we're helping ensure Ukraine's elite forces remain mission-capable. This program gives them an edge to keep pushing forward to victory."
The T3 Program aims to initially treat 400 elite Ukrainian soldiers, delivering immediate and lasting benefits both to these individuals and to the country. With rising demand for trauma-informed care, the program is expected to shape future best practices for treating combat-related PTSD and expand its services to thousands more.
Healing More Than Just Soldiers
This program isn't just about soldiers returning to the battlefield; it's about soldiers returning to their families, to their communities, and to the life they once knew. It's about healing the invisible wounds that war leaves behind. Every soldier treated in the T3 Program represents a ripple effect-helping to rebuild a stronger, more resilient Ukraine.
Mobbs continues: "We're giving them a lifeline back to normalcy, to stability. Every treatment administered is a victory in its own right, and the impact it will have on these defenders and their families cannot be overstated."
As the demand for trauma-informed care continues to rise, the T3 Program is expected to grow, reaching thousands more Ukrainian soldiers and informing global best practices for combat-related PTSD treatment. The lessons learned from this program will undoubtedly shape the future of trauma recovery for soldiers across the globe.
About the R.T. Weatherman Foundation
The Romulus T. Weatherman Foundation is a 501(c)(3) private operating foundation dedicated to supporting democracy, valuing each life, and meeting urgent needs in conflict zones. Through strategic partnerships and innovative programs, the foundation has become a leader in providing aid and care to those affected by war.
For more information, visit www.WeathermanFoundation.org
Contact Information
Meaghan Mobbs
President
meaghan@weathermanfoundation.org
7034020373
SOURCE: RT Weatherman Foundation
View the original press release on newswire.com.
